HLA-B* 5701 Genotyping
Abacavir is a core part of anti retroviral therapy used for the treatment of HIV. Patients with a HLA-B*5701 allele can have increased hypersensitivity to abacavir. In order to avoid the hypersensitivity in these patients, it is important to conduct HLA-B* 5701 genotyping prior to administration of Abacavir.
Accreditations
The above accreditations have been granted to NEUBERG SUPRATECH REFERENCE LABORATORIES PRIVATE LIMITED (NSRL). The Neuberg Center for Genomic Medicine (NCGM) is affiliated to NSRL.